Aegerion Pharmaceuticals to Present at the Jefferies Autumn 2015 Global Healthcare Conference


CAMBRIDGE, Mass., Nov. 13, 2015 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced today that the company will participate in the Jefferies Autumn 2015 Global Healthcare Conference in London. Gregory Perry, Chief Financial Officer of Aegerion, is scheduled to present in a fireside chat on Wednesday, November 18, 2015 at 2:40 p.m. GMT (9:40 a.m. EST).

The presentation will be webcast live and may be accessed for up to 30 days following the conference by visiting the “Investors” section of Aegerion’s website, www.aegerion.com.

About Aegerion Pharmaceuticals
Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. For more information about the company, please visit www.aegerion.com


            

Contact Data